Journal profile · Biochemistry, Genetics and Molecular Biology-Cell Biology
Cell Death Discovery
ISSN 2058-7716 · Springer Nature · ENGLAND · Founded 2015
Cell Death Discovery: CAS Zone 2 · Biology (2025 upgraded edition, Top journal); impact factor 10.37; fully open access; APC about USD 2,790; median 141 days to acceptance (129 articles, last 24 months); 622 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cell Death Discovery is published by Springer Nature and is in Zone 2 of Biology in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are RNA modifications and cancer, Cancer-related molecular mechanisms research and Ferroptosis and cancer prognosis, together about 24.9% of its articles. Its main subfields are Molecular Biology and Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)
Cell Death Discovery is committed to increasing the reproducibility of research. To this end, in conjunction with its sister journals Cell Death & Differentiation and Cell Death & Disease, Cell Death Discovery provides a unified forum for scientists as well as clinicians and members of the pharmaceutical and biotechnical industry. It is committed to the rapid publication of high quality original papers that relate to these subjects, together with topical, usually solicited, reviews, editorial correspondence and occasional commentaries on controversial and scientifically informative issues.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Cell Biology
Main research topics OpenAlex counts of recent articles; shares are approximate
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology9.4%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology8.8%
- Ferroptosis and cancer prognosisMedicine6.8%
- Autophagy in Disease and TherapyMedicine6.4%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5.2%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology4.9%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology4.7%
- Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Cell Biology | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 1 |
| Minor | Cell Biology | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Cell Biology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PMCPublisher website
Other: Google Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 10.37LetPub ·
- Impact factor (publisher) 2025
- 10.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 9.3Publisher website ·
- CiteScore 2026-06
- 13.2LetPub ·
- SJR 2026-06
- 2.67LetPub ·
- SNIP 2026-06
- 1.63LetPub ·
- h-index
- 108OpenAlex ·
- i10-index
- 2,173OpenAlex ·
- 2-year mean citedness
- 11.19OpenAlex ·
- Self-citation rate
- 1%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 597LetPub ·
- Downloads per year (publisher) 2025
- 7,628,507Publisher website ·
Articles by year OpenAlex count · 3,596 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 448 | 448 | 304 |
| 2025 | 622 | 622 | 6,293 |
| 2024 | 516 | 516 | 11,153 |
| 2023 | 470 | 470 | 13,523 |
| 2022 | 505 | 505 | 15,613 |
| 2021 | 400 | 400 | 15,976 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
141 daysMedian, submission to acceptance · P25–P75 111 days – 188 days
- Acceptance to online
- median 15 days (129 articles)
- Submission to online
- median 159 days
- Sample
- 129 articles with submission and acceptance dates (1,156 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 9 weeksLetPub ·
- Submission to publication (journal-reported)
- about 9 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,490 / USD 2,790 / GBP 2,290 | Yes | CC BY | |
| OpenAlex | USD 2,690 / EUR 2,390 / GBP 2,190 | — | — | |
| LetPub | GBP 2,090 / USD 2,590 / EUR 2,290 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- ENGLAND
- Language
- English
- Founded
- 2015
- ISSN
- 2058-7716
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cell Death Discovery
What CAS zone is Cell Death Discovery in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cell Death Discovery is in Zone 2 of Biology, and in Zone 2 of the minor category Cell Biology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cell Death Discovery?
The latest impact factor listed by LetPub is 10.37; CiteScore 13.2, h-index 108.
How long does peer review take at Cell Death Discovery?
Based on the dates recorded on 129 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 141 days (interquartile range 111–188 days); authors report an average review time of about 9 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Cell Death Discovery?
According to LetPub and DOAJ records, Cell Death Discovery is indexed in SCIE, Scopus and DOAJ. The journal's website also lists PMC; that list has not been checked against each database.
Is Cell Death Discovery open access, and what is the APC?
Cell Death Discovery is a fully open-access journal. APC about USD 2,790.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .